Filing Details
- Accession Number:
- 0001628280-25-009076
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-02-28 16:30:17
- Reporting Period:
- 2025-02-27
- Filing Date:
- 2025-02-28
- Accepted Time:
- 2025-02-28 16:30:17
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1157601 | Madrigal Pharmaceuticals Inc. | MDGL | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1210238 | Kenneth Bate | C/O Madrigal Pharmaceuticals, Inc. 200 Barr Harbor Drive, Suite 400 West Conshohocken PA 19428 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-02-27 | 6,000 | $111.06 | 7,912 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2025-02-27 | 9,470 | $65.06 | 17,382 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2025-02-27 | 4,530 | $9.45 | 21,912 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2025-02-27 | 100 | $351.01 | 21,812 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-02-27 | 500 | $351.99 | 21,312 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-02-27 | 238 | $353.83 | 21,074 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-02-27 | 8,545 | $355.08 | 12,529 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-02-27 | 2,791 | $356.51 | 9,738 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-02-27 | 2,038 | $357.27 | 7,700 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-02-27 | 3,548 | $358.33 | 4,152 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-02-27 | 2,024 | $359.21 | 2,128 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-02-27 | 216 | $360.07 | 1,912 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2025-02-27 | 6,000 | $0.00 | 6,000 | $111.06 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2025-02-27 | 9,470 | $0.00 | 9,470 | $65.06 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2025-02-27 | 4,530 | $0.00 | 4,530 | $9.45 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2025-06-17 | No | 4 | M | Direct | |
| 0 | 2025-06-16 | No | 4 | M | Direct | |
| 5,470 | 2026-07-22 | No | 4 | M | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $350.98 to $351.01, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and the footnotes below.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $353.78 to $354.50, inclusive.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $354.79 to $355.78, inclusive.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $355.83 to $356.79, inclusive.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $356.83 to $357.79, inclusive.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $357.91 to $358.83, inclusive.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $358.94 to $359.84, inclusive.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $359.99 to $360.17, inclusive.
- The shares underlying this stock option are fully vested and exercisable.
Billionaire Hedge Funds
